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Simple Summary: The main goal of breeding programs for broiler chickens is to increase growth
rate and breast and thigh muscles weight. The candidate gene approach is a powerful technique
for genetically improving performance traits in chickens. We studied the associations of the single
nucleotide polymorphisms of three genes involved in protein synthesis, glucose metabolism and cell
proliferation (IGF1, IGFBP2, TGFβ3) with performance traits in the Hubbard F15 and Cobb E chicken
lines. Based on our results, it can be concluded that the TGFβ3 gene could be used as a candidate
gene marker for chicken growth traits.
Abstract: Marker-assisted selection based on fast and accurate molecular analysis of individual genes
is considered an acceptable tool in the speed-up of the genetic improvement of production performance
in chickens. The objective of this study was to detect the single nucleotide polymorphisms (SNPs) in
the IGF1, IGFBP2 and TGFß3 genes, and to investigate their associations with growth performance
(body weight (BW) and average daily gain (ADG) at 14, 21, 28, 35 and 42 days of age) and carcass
traits in broilers. Performance (carcass) data (weight before slaughter; weights of the trunk, giblets,
abdominal fat, breast muscle and thigh muscle; slaughter value and slaughter percentage), as well as
blood samples for DNA extraction and SNP analysis, were obtained from 97 chickens belonging to two
different lines (Hubbard F15 and Cobb E) equally divided between the two sexes. The genotypes were
detected using polymerase chain reaction- restriction fragment length polymorphism (PCR-RFLP)
methods with specific primers and restrictase for each gene. The statistical analysis discovered
significant associations (p < 0.05) between the TGFβ3 SNP and the following parameters: BW at
Animals 2020, 10, 800; doi:10.3390/ani10050800 www.mdpi.com/journal/animals
Animals 2020, 10, 800 2 of 24
21, 28 and 35 days, trunk weight and slaughter value. Association analysis of BWs (at 21, 28 and
35 days) and SNPs was always significant for codominant, dominant and overdominant genetic
models, showing a possible path for genomic selection in these chicken lines. Slaughter value was
significant for codominant, recessive and overdominant patterns, whereas other carcass traits were
not influenced by SNPs. Based on the results of this study, we suggested that the TGFβ3 gene could be
used as a candidate gene marker for chicken growth traits in the Hubbard F15 and Cobb E population
selection programs, whereas for carcass traits further investigation is needed.
Keywords: chicken; SNP; IGF1; IGFBP2; TGFß3; Hubbard F15; Cobb E; growth; meat
1. Introduction
With the growth of the human population [1], the total amount of meat consumed increases at
a global level worldwide [2]. Meat consumption rose worldwide from 23.08 kg per person per year in
1961 to 43.22 kg per person per year in 2013 [2]. Chicken meat is one of the most consumed types of
meat worldwide [3].
Growth performance and carcass traits are the most important economic traits in broiler chicken
production, and are controlled by a number of genes [4]. Growth is a complex process that involves
the regulated coordination of a wide range of neuroendocrine pathways [5]. Therefore, it is very
difficult to achieve rapid genetic improvement in these traits using only traditional selection methods.
The growing knowledge of the structure and function of the chicken genome can be beneficial, and can
lead to the recognition of causal genes and the development of new selectable molecular markers.
Although the Gallus gallus (chicken) genome was first sequenced as early as 2004 [6], it still required
further improvements [7–9]. The newest version of the chicken genome assembly (Gallus_gallus-5.0;
GCA_000002315.3), built from combined long single molecule sequencing technology, finished bacterial
artificial chromosomes (BACs) and improved physical maps, was presented in 2017 [10]. Since the
methodological approach has improved, the originally reported size of the chicken genome has increased
from 1.05 [6] to 1.23 Gb, which has contributed to the increased number of genes observed [10].
Initial assemblies have been found insufficient for the more complete discovery of allelic contributions to
complex traits [10], leading to ongoing efforts to improve the quality of the chicken reference genome [8,11].
However, the genetic improvement of polygenic traits, including growth performance and meat
production, can be accomplished by marker-assisted selection that is more accurate in estimating
the animal’s genetic value [12]. The molecular markers linked to quantitative trait loci (QTLs) are
not affected by environmental conditions. Therefore, they could increase the speed and effectiveness
of animal breeding progress. As soon as the relationship between a DNA polymorphism and
an important trait is revealed, the DNA marker may be used [13]. The candidate gene approach has
become a powerful technique for the genetic improvement in chicken breeding programs, and can
result in increased efficiency in detecting the required production performance traits [4].
The main objectives of the strategy in commercial broiler breeding programs include increasing
growth rate and breast muscle weight, reducing abdominal fat content, improved feed efficiency
and increased fitness. The relationships between these individual production traits are very complex
and some of them are very difficult to measure. Therefore, the use of molecular marker-assisted
selection (MMAS) is necessary. In case that the favorable allele is rare, a larger positive impact can
be expected [14].
The purpose of the present study was to identify polymorphisms and evaluate the association
between polymorphisms in three studied genes—IGF1 (insulin-like growth factor 1), IGFBP2
(insulin-like growth factor binding protein 2) and TGFß3 (transforming growth factor β)—with
growth performance and meat production in chickens from two broiler lines: Hubbard F15 and Cobb
E. The biological functions and interdependence of these genes are shown in Figure 1.
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Figure 1. Signaling cascade of insulin-like growth factor 1 (IGF-1) and its potential impacts in metabolism,
its interactions with transforming growth factor β3 (TGF-β3) and the biological functions of the IGF1, IGFBP2
and TGFß3 genes. IGF-1 bioavailability is modulated by IGF binding proteins (IGFBPs) [15]. IGF-1 action is
mediated by its binding to its receptor [16], the type 1 insulin-like growth factor receptor (IGF-1R). IGF-1R is
a heterotetramer composed of two extracellular α subunits and two transmembrane β subunits, as shown
in Figure 1. α subunits are cysteine-rich regions, whereas β subunits possess a tyrosine kinase domain,
which constitutes the signal transduction mechanism [16]. Tyrosine phosphorylation activates a signaling
cascade [17]. IGF-1 has autocrine, paracrine [18,19] and endocrine effects [18]. IGF-1 binds to its receptor (IGF-1R)
in the cell membrane, resulting in autophosphorylation and the recruitment of the adaptor proteins–insulin
receptor substrate IRS-1, IRS-2, and the proto-oncogene tyrosine-protein kinase (SRC) homology and collagen
protein (SHC). The serine/threonine kinase (AKT) is activated by the 3-phosphoinositide-dependent protein
kinase-1 (PDK1) and by the mammalian target of rapamycin (mTOR)-containing complex mTOR-C2, leading
to the phosphorylation at threonine 308 and serine 473, respectively. Activated AKT regulates downstream
signaling molecules such as tuberous sclerosis protein 1/2 (TSC-1/2), which inhibit mTOR-C1 complex
and regulate the ribosomal protein S6 kinase 1/2 (S6K-1/2) and eukaryotic translation initiation factor 4E
(eIF4E)-binding protein 1 (4EB-P1) phosphorylation, FOXO transcription factors, glycogen synthase kinase-3β
(GSK-3β), p27, BCL-2 antagonist of cell death (BAD), and BCL-2. These substances are involved in some cellular
processes such as protein synthesis, glucose metabolism and cell survival. SHC activation induces the activation
of the RAS/mitogen-activated protein (MAP) kinase pathway, resulting in enhanced cell proliferation [15].
Activation of IRS induces the activation of intracellular RAF/MEK/ERK/RAS and PI3K signaling pathway.
The first mentioned pathway mediates mitosis, and the second one mediates metabolism and cell growth effect
through AKT [20]. After the ligand (IGF-1) binds to its receptor (IGF-1R), PI3K is activated, cell proliferation
is promoted by activating the mitogen-activated protein kinase (MAPK) cascade, and apoptosis is blocked
by inducing the phosphorylation and the inhibition of proapoptotic proteins such as BAD [21]. The protein
IGFBP-2 encoded by the gene of the same name is able to control the biological actions of IGFs [22] and
TGFß [23] in vivo via the endocrine, autocrine or paracrine pathways. The protein TGFß-3 encoded by the
TGFβ3 gene controls the growth, proliferation and differentiation of cells, cell motility and apoptosis. TGFß-3
plays an essential role in the development of skeletal muscles. It also can suppress the formation of tumors [24].
Adapted from [15,25–27] based on other works: [21,28–53].
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The insulin-like growth factor 1 gene (IGF1) has been identified as a biological candidate gene for
growth, body composition, metabolic and skeletal characteristics, and is also a positional candidate
gene for growth and fat deposition in chicken [54]. This gene is involved in growth of various tissues
such as muscle and bones [55]. The chicken IGF1 gene was mapped to 165.95 cM on chromosome 1
(GGA1). In a broiler-layer F2 population used to map body weight (BW) QTL by a genome scan, a QTL
affecting BW at 6 weeks of age has been detected at 160 cM (confidence interval (CI) 114 to 180 cM) on
chicken GGA1 [56]. In the same F2 cross, a QTL at 150 cM (CI from 100 to 182 cM) on GGA1 affecting
abdominal fat weight (AFW) has been ascertained [57].
The bioavailability of the insulin-like growth factors (IGFs) is regulated by a family of structurally
conserved insulin-like growth factor binding proteins (IGF-binding proteins; IGFBPs) [58–60]. IGFBPs
selectively bind to IGF-1 and IGF-2 proteins but do not bind to insulin [61]. More than 99% of
IGF molecules circulate in blood serum as complexes with these specific and high affinity-binding
proteins. Although IGF-binding protein 3 (IGFBP-3) is a main component and binds over 75% of the
circulating IGF [62], IGFBP-2 is sensitive to dietary protein level, and may play a substantial role in the
modulation of the growth-promoting effect of circulating IGF-1 by creating the IGF-1-IGFBP-2 complex
in chickens [63]. IGFBP-2 is the predominant IGFBP in serum for different species [64]. IGFs, IGFBPs
and IGFBP proteases are the major regulators of somatic growth and cell proliferation [65]. IGFBP-2
controls the biological actions of IGFs [22] and TGFs [23] in vivo via endocrine [22,23], autocrine [23]
or paracrine mechanisms [22], and affects the growth and development of animals [66]. IGFBP-2
might indirectly affect adipocyte differentiation by controlling IGF [67] and TGF-β biological actions in
fat tissue [68].
The transforming growth factor β (TGF-β) belongs to a large family of multifunctional growth
factors [69], with important regulatory roles in embryonic and adult development [70], such as
morphogenesis, development and differentiation [69]. Polypeptide growth factors of TGF-β family
regulate a number of cellular processes such as cell proliferation, differentiation, migration, adhesion and
apoptosis [70]. TGF-β plays a key role in maintaining both bone and articular cartilage homeostasis [71].
2. Materials and Methods
2.1. Experimental Population—Animals
The chicken hatching eggs were produced and the experiment was performed in the testing station
of broilers (fattening test No. 1148) at the state-owned enterprise International Testing of Poultry,
Ustrasice (Czech Republic). After hatching, 50 chickens from each of the two broiler lines Hubbard
F15 and Cobb E were stalled in windowless air-conditioned hall with deep bedding and controlled
light mode (Table 1). Stocking density was 6.1 chicks/m2. The hall was disinfected with Virkon before
the chickens were stored. The chickens were watered by automatic dropper drinking basins and fed
with three feed mixtures, differently for particular period of fattening, from tube feeders ad libitum.
Hypermangan solution was applied to the water in the first days of age. The composition (contents of
main nutrients) in individual complete feed mixtures BR1, BR2 and BR3 for fattening broiler chickens
up to the 10th, 35th and 42nd day of age, respectively, are shown in Table 2.
Table 1. Light regime in the chicken house.
Day
The Proportion of Light
and Darkness Within 24 h
Light (h) Dark (h)
1–7 23 1
8–37 18 6
38 20 4
39 22 2
40–42 23 1
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Table 2. The content of nutrients in feeding mixtures for broilers (BR1, BR2, BR3) in different periods of
the experiment.
Nutrient
Feeding Mixture *
BR1 BR2 BR3
Period
1st–10th Day 11th–35th Day 36th–42nd Day
Crude protein (%) 22.01 19.86 18.50
Fat (%) 3.85 5.76 7.64
Lysine (%) 1.16 1.22 1.07
Methionine (%) 0.56 0.56 0.51
Calcium (%) 0.91 0.84 0.81
Phosphorus (%) 0.60 0.54 0.47
Vitamin A (IU/kg) 15,300 12,300 10,300
Vitamin D3 (IU/kg) 5,000 5,000 5,000
Metabolizable energy (MJ/kg) 12.64 13.07 13.59
* The feeding mixtures were produced in ZZN Pelhrimov, a.s., according to given recipes.
2.2. Phenotypic Data
Body weight (BW) was measured at 14, 21, 28, 35 days and before slaughter at 42 days of age.
The mortality during experiment was 3% (sudden death syndrome). Chickens were slaughtered at
42 days of age and the slaughter analysis was performed. The carcass traits, such as weight of trunk,
giblets, abdominal fat, breast muscle (with and without skin) and thigh muscle (with and without
skin), as well as slaughter value and slaughter percentage were investigated. The slaughter value was
calculated as the ratio between the weight of the carcass (trunk weight) and the weight at 42 days of
age before slaughter, and the slaughter percentage was calculated as the ratio between the sum of
weight of the trunk and giblets and the weight at 42 days.
2.3. SNP Genotyping
2.3.1. DNA Extraction
Genomic DNA for genotyping assays was extracted from whole blood samples, which were
collected from 97 chickens at 42 days of age before slaughtering. Blood was taken from vena ulnaris
into 1.5 mL EDTA-treated microtubes. For extraction of genomic DNA, chelex 100 was used, and the
concentration and purity of genomic DNA were verified by spectrophotometer Shimadzu BioSpec-nano
(Shimadzu Corporation, Kyoto, Japan).
2.3.2. Optimalization of PCR-RFLP Assay
Polymerase chain reaction (PCR) was performed for all assays in total volume 25 µL mixture
containing 1 µL genomic DNA, 10 pmol of each primer and 12.5 µL PPP Master Mix (Top-Bio, s.r.o.,
Vestec, Czech Republic). Sequences of sets of primer pairs for all three gene polymorphisms used
in PCR assays are shown in Table 3.The primers for the IGF1 genotyping were designed according
to Moody et al. [72]. The thermal profile included pre-denaturation at 94 ◦C for 2 min followed
by 30 cycles 94 ◦C for 30 s, 67 ◦C for 30 s and 72 ◦C for 50 s, with a final extension of 72 ◦C for
7 min. Thermocycler BIOER Life ECO (Hangzhou Bioer Technology Co,. Ltd., Bin An Rd, Hi-tech
(Binjiang) District, Hangzhou, China) was used for DNA amplification. SNP of IGF1 gene was detected
after digesting PCR product with Hinf I restriction endonuclease (Fermentas, Vilnius, Lithuania) at
37 ◦C overnight. For detection of IGFBP2 genotypes PCR amplification was done using primer set
by Li et al. [73]. Amplification was performed under following conditions: pre-denaturation at 94 ◦C
for 2 min followed by 30 cycles 94 ◦C for 30 s, 54 ◦C for 30 s and 72 ◦C for 30 s, with a final extension
of 72 ◦C for 7 min. PCR products were digested (restriction fragment length polymorphism–RFLP)
with Eco72I restriction endonuclease (New England Biolabs, Ipswich, MA, USA) at 37 ◦C overnight.
The PCR primers designed by Li et al. [69] were applied for TGFβ3. The PCR reaction conditions
were the same as for IGFBP2, except the annealing temperature which was 58 ◦C. Gene fragments
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were subjected to digestion by BslI restriction enzyme (New England Biolabs, Ipswich, MA, USA) at
37 ◦C overnight.
Table 3. Primers used in polymerase chain reaction (PCR) assay.
Gene Primer Sequence ProductLength (bp)
Restriction
Enzyme
Restriction Enzyme
Production Size (bp) *
IGF1
SNP/site
A>C/Promoter and 5′UTR
forward a 5’-CATTGCGCAGGCTCTATCTG-3´
813 Hinf I
AA: 378+244+191
AC: 622+378+244+191
CC: 622+191reverse
a 5´-TCAAGAGAAGCCCTTCAAGC-3´
IGFBP2
intron 2 C1032T (accession number
AY 326194)
forward b 5´-GTCCCAGATAAACCTTGCT-3´
367 Eco72I
AA: 367
AB: 367+265+102
BB: 265+102reverse
b 5´-GCTGGCAAGGGGTCTG-3´
TGFβ3
A C/A SNP at base 2,833 (accession
number X60091)
forward c 5´-TCAGGGCAGGTAGAGGGTGT-3´
294 BslI
AA: 145+75+74
AB: 145+125+75+74
BB: 125+75+74+20reverse
c 5´-GCCACTGGCAGGATTCTCAC-3´
a Moody et al. (2003) [72], Zhou et al. (2005) [54]. b Li et al. (2006) [73]. c Li et al. (2003) [69]. * All possibilities
of fragments.
2.3.3. Electrophoresis
The PCR products were visualized by 2% and restriction patterns by 3% agarose gel electrophoresis
and ethidium bromide staining. The ENDURO™ 250 V power supply (Labnet International, Inc.,
New York, USA) and the HU13 midi horizontal gel electrophoresis unit (Scie-Plas Ltd., Cambourne,
Cambridge, UK) were used for DNA electrophoresis. Syngene™ Ingenius 3 Manual Gel Documentation
System (Syngene) was used for photo-documentation.
2.4. Statistical Analysis
Associations of three different polymorphisms of IGF1, IGFBP2 and TGFβ3 genes with growth
characteristics and carcass data in 97 chicken belonging to two different lines (Hubbard F15 and Cobb
E), equally divided between two sexes, were studied. Genotypes were tested for Hardy-Weinberg
equilibrium (HWE) using a chi-square (χ2) test in R/SNPassoc Package (R Development Core
Team). Whole-Genome association analyses were performed assuming five different genetic models
(inheritance patterns) using R/SNPassoc Package (R Development Core Team): codominant, dominant,
recessive, overdominant and log-additive effect. The level of significance was tested at the nominal 5%
significance level after correcting for the number of tests performed (Bonferroni correction). Phenotypes
were represented by the carcass data collected on poultry, whereas line and sex were included in the
model as fixed effects. Hardy-Weinberg equilibrium (HWE) was calculated and tested using χ2 test at
the 0.05 level of statistical significance.
Another statistical analysis was performed using box and forest plots. Average slopes of growth
curve and total integrals for the weight sum of the trunk, giblets, abdominal fat, breast and thigh
muscles at 42 days of age (at the slaughter of chickens) in both chicken lines, for both sexes and for all
genotypes observed, were evaluated using the laboratory information system Qinslab (Prevention
Medicals, Studenka, Czech Republic).
3. Results
The IGF1/Hinf I PCR-RFLP analysis of 97 DNA samples obtained from chicken belonging to broiler
lines Hubbard F15 and Cobb E showed only two from three genotypes, namely AA (378 + 244 + 191 bp),
and AC (622 + 378 + 244 + 191 bp), as shown in Figure 2. The AA homozygotes (73.20%) predominated
over heterozygotes (26.80%)–Table 4, Figure 3. No CC homozygous individuals were detected on either
of the two broiler lines. Correspondingly, the frequency of allele A is much higher (86.60%) than allele
C (13.40%) in the investigated chicken population, as is evident from Table 4.
In contrast, in IGFBP2/Eco72I polymorphism, all three genotypes (AA, AB, and BB) were found,
however, BB (265 + 102 bp) homozygotes showed very low frequency (4.12%). The most represented
genotype was AB (367 + 265 + 102 bp) with a frequency of 56.70%.
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Also, in TGFß3/BslI SNP, all three genotypes were detected, with the highest observed genotypic
frequency in heterozygotes (42.27%) followed by 36.08% and 21.65% in AA (145 + 75 + 74 bp) and BB
(125 + 75 + 74 + 20 bp), respectively.
Only for IGFBP2 frequencies in total population, Hardy-Weinberg equilibrium (HWE) was
identified: p < 0.01.
Figure 2. The restriction fragment length polymorphism (RFLP) patterns for IGF1 (AA: 378 + 244 +
191 bp; AC: 622 + 378 + 244 + 191 bp; CC–it was not detected), IGFBP2 (AA: 367 bp; AB: 367 + 265 +
102 bp; BB: 265 + 102 bp) and TGFβ3 (AA: 145 + 75 + 74 bp, AB: 145 + 125 + 75 + 74 bp; BB: 125 + 75
+ 74 + 20 bp). Agarose 2%, 120 V, 60 min, Tris-borate-ethylenediaminetetraacetic acid (EDTA) (TBE)
buffer. M–marker.
Table 4. Genotype and allele frequencies of IGF1, IGFBP2 and TGFβ3 genes in the chicken population.
Broiler Line Gene Genotype Frequencies a Allele Frequencies a
χ2 Test
HWE b
(p-Value)
Hubbard F15
IGF1
AA AC CC A C
28
(56.00)
22
(44.00) nf
78
(78.00)
22
(22.00) 0.0908
IGFBP2
AA AB BB A B
20
(40.00)
27
(54.00)
3
(6.00)
67
(67.00)
33
(33.00) 0.1998
TGFβ3
AA AB BB A B
15
(30.00)
20
(40.00)
15
(30.00)
50
(50.00)
50
(50.00) 0.1639
Cobb E
IGF1
AA AC CC A C
43
(91.49)
4
(8.51) nf
90
(95.74)
4
(4.26) 1.00
IGFBP2
AA AB BB A B
18
(38.30)
28
(59.57)
1
(2.13)
64
(68.09)
30
(31.91) 0.0172*
TGFβ3
AA AB BB A B
20
(42.55)
21
(44.68)
6
(12.77)
61
(64.89)
33
(35.11) 1.00
Total
IGF1
AA AC CC A C
71
(73.20)
26
(26.80)
0
(0)
168
(86.60)
26
(13.40) 0.2066
IGFBP2
AA AB BB A B
38
(39.18)
55
(56.70)
4
(4.12)
131
(67.53)
63
(32.47) 0.0050*
TGFβ3
AA AB BB A B
35
(36.08)
41
(42.27)
21
(21.65)
111
(57.22)
83
(42.78) 0.2125
a The numbers in brackets are percentage frequencies (relative frequencies). b HWE–Hardy-Weinberg equilibrium;
* statistically significant (p < 0.05); nf–not found.
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Figure 3. Genotype distribution of individual genes in both chicken lines.
Tables 5–7 show average values of growth performance and carcass traits in both chicken lines,
according to individual genotypes. The highest average BW at 42 days was achieved in the Cobb E
line, with the AC genotype of IGF1 (2967.50 g), BB genotype of IGFBP2 (3170.00 g) and the AB genotype
of TGFβ3 (3104.29 g). The highest average breast muscle (without skin) was found in a Cobb E chicken
with an AC genotype of IGF1 (629.25 g), a BB genotype of IGFBP2 (753.00 g) and an AB genotype
of TGFβ3 (653.62 g). The Cobb E chicken with an AC genotype of IGF1 (52.50 g) and a BB genotype
of IGFBP2 (63.00 g) also had the highest average abdominal fat weight (AFW); whereas for TGFβ3,
the highest AFW was found in the AA genotype (54.95 g). The highest average thigh muscle (with skin)
were measured in a Cobb E line chicken with an AC genotype of IGF1 (519.75 g), a BB genotype of
IGFBP2 (552.00 g) and an AB genotype of TGFβ3 (538.72 g). On the contrary, the lowest average values
of BW at 42 days and AFW showed in the Hubbard F15 line chicken with an AA genotype of IGF1
(2585.00 and 35.32 g, respectively), a BB genotype of IGFBP2 (2413.33 g and 30.33 g, respectively) and
an AA genotype of TGFβ3 (2541.33 g and 31.53 g). The lowest breast muscle (without skin) showed
the Hubbard F15 line chicken with an AA genotype of IGF1 (501.75 g), an AA genotype of IGFBP2
(498.75 g) and an AA genotype of TGFβ3 (494.33 g). The lowest thigh muscle (with skin) was observed
in a Hubbard F15 line chicken with an AA genotype of IGF1 (470.68 g) and a BB genotype of IGFBP2
(445.00 g) and in a Cobb E line chicken with a BB genotype of TGFβ3 (458.67 g).
Table 5. The average growth performance and carcass traits in the chicken population (according to
IGF1 genotypes).
Parameter
Line
Hubbard F15 Cobb E
Genotype Genotype
AA (n = 28) AC (n = 22) CC AA (n = 43) AC (n = 4) CC
Mean ± SD; CI
BW at 14 days * 421.07 ± 32433; 408
428.18 ± 31
442; 414 -
473.24 ± 40
485; 461
462.50 ± 43
530; 394 -
BW at 21 days * 840.00 ± 69866; 813
865.00 ± 67
894; 835 -
933.25 ± 96
962; 903
940.00 ± 113
1120; 760 -
BW at 28 days * 1393,21 ± 1371446; 1340
1436.82 ± 114
1487; 1386 -
1558.84 ± 182
1614; 1502
1552.50 ± 204
1877; 1227 -
BW at 35 days * 1913.21 ± 1831984; 1842
1947.27 ± 161
2018; 1876 -
2103.95 ± 240
2178; 2030
2152.50 ± 281
2600; 1705 -
BW at 42 days
before slaughter *
2585.00 ± 298
2700; 2469
2588.64 ± 265
2706; 2471 -
2919.77 ± 318
3018; 2822
2967.50 ± 415
3627; 2308 -
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Table 5. Cont.
Parameter
Line
Hubbard F15 Cobb E
Genotype Genotype
AA (n = 28) AC (n = 22) CC AA (n = 43) AC (n = 4) CC
Mean ± SD; CI
Trunk weight * 1798.00 ± 1901871; 1724
1817.45 ± 188
1901; 1734 -
1989.60 ± 224
2058; 1920
2060.25 ± 289
2520; 1600 -
Giblets weight * 156.79 ± 18163; 149
161.45 ± 14
168; 155 -
169.14 ± 18
174; 163
165.50 ± 21
199; 132 -
Abdominal fat
weight *
35.32 ± 9
38; 32
35.68 ± 13
41; 30 -
51.47 ± 12
55; 47
52.50 ± 17
80; 25 -
Breast muscle
with skin *
542.18± 53
562; 521
558.00± 64
586; 529 -
668.81± 84
694; 643
684.50± 106
853; 515 -
Breast muscle
without skin *
501.75 ± 50
521; 482
517.09 ± 61
544; 489 -
615.98 ± 83
641; 590
629.25 ± 98
712; 530 -
Thigh muscle
with skin *
470.68 ± 61
494; 447
475.14 ± 55
499; 450 -
499.98 ± 60
519; 584
519.75 ± 94
669; 371 -
Thigh muscle
without skin *
421.39 ± 55
442; 400
426.77 ± 53
450; 402 -
441.88 ± 60
460; 423
464.25 ± 90
608; 320 -
Slaughter value ** 69.66 70.22 - 68.14 69.42 -
Slaughter
percentage *** 75.74 76.48 - 73.94 75.01 -
BW–average body weight; SD–standard deviation; CI–confidence interval (95%); * (g); ** slaughter value = weight of
trunk/BW at 42 days * 100 (%); *** slaughter percentage = weight of trunk+ weight of giblets/BW at 42 days * 100 (%).
Table 6. The average growth performance and carcass traits in the chicken population (according to
IGFBP2 genotypes).
Parameter
Line
Hubbard F15 Cobb E
Genotype Genotype
AA (20) AB (27) BB (3) AA (17) AB (27) BB (1)
Mean ± SD; CI
BW at 14 days * 419.50 ± 33435; 403
427.78 ± 32
440; 415
423.33 ± 15
461; 385
468.82 ± 39
489; 449
474.81 ± 43
492; 458 460.00
BW at 21 days * 839.50 ± 72873; 805
864.07 ± 66
890; 838
810.00 ± 62
965; 655
927.65 ± 95
976; 879
932.22 ± 103
973; 892 1010.00
BW at 28 days * 1392.50 ± 1281452; 1333
1436.67 ± 128
1487; 1385
1326.67 ± 90
1552; 1101
1535.29 ± 184
1630; 1441
1554.81 ± 184
1628; 1482 1750.00
BW at 35 days * 1894.00 ± 1791978; 1810
1967.78 ± 164
2032; 1902
1800.00 ± 125
2110; 1489
2096.47 ± 232
2216; 1977
2097.41 ± 256
2199; 1996 2300.00
BW at 42 days
before slaughter *
2578.50 ± 320
2728; 2428
2611.85 ± 257
2713; 2510
2413.33± 240
3009; 1818
2891.76 ± 344
3069; 2716
2912.59 ± 311
3036; 2789 3170.00
trunk weight * 1791.20 ± 2061887; 1695
1827.41 ± 178
1898; 1757
1721.33 ± 157
2110; 1333
1958.06 ± 226
2074; 1842
1996.22 ± 228
2086; 1906 2251.00
giblets weight * 159.45 ± 19168; 151
159.44 ± 15
165; 154
149.33 ± 18
194; 105
166.53 ± 20
177; 156
168.74 ± 18
176; 162 194.00
abdominal fat
weight *
35.55 ± 11
41; 30
36.00 ± 9
40; 32
30.33 ± 18
75; (-14)
50.59 ± 13
57; 44
51.26 ± 12
56; 46 63.00
breast muscle
with skin *
539.65 ± 64
569; 510
555.85 ± 56
578; 533
552.00 ± 33
634; 470
651.24 ± 74
689; 613
676.11 ± 90
712; 641 809.00
breast muscle
without skin *
498.75 ± 60
527; 471
515.59 ± 53
537; 495
509.67 ± 36
600; 420
598.82 ± 72
636; 562
622.37 ± 89
658; 587 753.00
thigh muscle
with skin *
471.80 ± 63
501; 442
476.33 ± 56
498; 454
445.00 ± 52
575; 316
488.06 ± 65
522; 455
503.33 ± 61
527; 479 552.00
thigh muscle
without skin *
423.25 ± 59
451; 396
426.74 ± 52
447; 406
400.33 ± 49
522; 278
431.24 ± 63
464; 399
445.56 ± 62
470; 421 487.00
slaughter value ** 69.57 69.99 71.36 67.77 68.51 71.01
slaughter
percentage *** 75.78 76.12 77.54 73.53 74.31 77.13
BW–average body weight; SD–standard deviation; CI–confidence interval (95%); * (g); ** slaughter value = weight of
trunk/BW at 42 days * 100 (%); *** slaughter percentage = weight of trunk + weight of giblets/BW at 42 days * 100 (%).
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Table 7. The average growth performance and carcass traits in the chicken population (according to
TGFβ3 genotypes).
Parameter
Line
Hubbard F15 Cobb E
Genotype Genotype
AA (15) AB (20) BB (15) AA (20) AB (21) BB (6)
Mean ± SD; CI
BW at 14 days * 420.67 ± 40443; 398
433.00 ± 24
444; 422
416.00 ± 30
433; 399
462.00 ± 38
480; 444
484.76 ± 41
503; 466
463.33 ± 34
499; 428
BW at 21 days * 842.67 ± 72883; 803
866.00 ± 65
896; 836
839.33 ± 72
879; 799
888.50 ± 93
932; 845
980.00 ± 91
1021; 939
923.33 ± 50
976; 871
BW at 28 days * 1399.33 ± 1221467; 1332
1420.50 ± 117
1475; 1366
1414.67 ± 154
1499; 1330
1453.00 ± 167
1531; 1375
1664.76 ± 149
1733; 1597
1536.67 ± 125
1668; 1405
BW at 35 days * 1884.67 ± 1711979; 1790
1938.00 ± 165
2015; 1861
1958.67 ± 187
2062; 1855
1986.00 ± 240
2098; 1874
2241.91 ± 190
2328; 2155
2046.67 ± 176
2231; 1862
BW at 42 days
before slaughter *
2541.33 ± 255
2682; 2400
2597.00 ± 302
2738; 2456
2618.00 ± 292
2780; 2456
2778.50 ± 312
2924; 2633
3104.29 ± 270
3227; 2982
2780.00 ± 208
2998; 2562
trunk weight * 1773.27 ± 1751870; 1676
1825.40 ± 209
1923; 1728
1814.73 ± 177
1913; 1717
1896.95 ± 223
2001; 1793
2129.19 ± 181
2211; 2047
1857.00 ± 136
1999; 1715
giblets weight * 159.00 ± 15168; 150
158.15 ± 19
167; 149
159.60 ± 15
168; 151
161.45 ± 19
170; 153
177.43 ± 16
185; 170
163.33 ± 14
178; 148
abdominal fat
weight *
31.53 ± 7
35; 28
37.05 ± 13
43; 31
37.33 ± 10
43; 32
54.95 ± 14
62; 48
48.90 ± 9
53; 45
49.50 ± 15
66; 33
breast muscle
with skin *
533.67 ± 59
566; 501
555.15 ± 68
587; 523
556.60 ± 41
580; 534
648.30 ± 86
689; 608
710.48 ± 72
743; 678
601.83 ± 51
656; 548
breast muscle
without skin *
494.33 ± 54
525; 465
515.55 ± 66
546; 485
513.27 ± 39
535; 491
598.60 ± 86
639; 559
653.62 ± 73
687; 621
551.00 ± 52
605; 497
thigh muscle with
skin *
469.00 ± 63
504; 434
476.75 ± 63
506; 447
470.80 ± 49
498; 444
475.65 ± 61
504; 447
538.72 ± 51
562; 516
458.67 ± 30
490; 428
thigh muscle
without skin *
421.47 ± 56
453; 390
429.10 ± 61
458; 401
418.93 ± 45
444; 394
419.65 ± 61
448; 391
477.05 ± 54
502; 452
407.83 ± 32
441; 375
slaughter value * * 69.80 70.34 69.44 68.26 68.62 66.93
slaughter
percentage * * * 76.08 76.43 75.57 74.08 74.34 72.81
BW–average body weight; SD–standard deviation; CI–confidence interval (95%); * (g); ** slaughter value = weight of
trunk/BW at 42 days * 100 (%); *** slaughter percentage = weight of trunk + weight of giblets/BW at 42 days * 100 (%).
By means of statistical software analysis, the relationships between SNPs and individual traits
were identified. The fixed effects included in the “whole” model were sex and line, and the p-values
obtained were adjusted by the number of tests using Bonferroni correction.
Only the TGFβ3 SNP (Table 8) resulted in statistical significance for the following parameters:
body weight at 21, 28 and 35 days, trunk weight and slaughter value. The p values were significant for
codominant, dominant and overdominant genetic models, with the exception of the slaughter value,
which was not significant for the dominant inheritance pattern.
Figure 4 shows average slopes of growth curve (14–42 days of age) in individual genotypes of
both chicken line and sexes.
Figure 5 represents total integrals for the sum of the trunk, giblets, abdominal fat, breast and thigh
muscles at 42 days of age in all genotypes observed.
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Table 8. Results of statistical analysis for testing association between TGFβ3 polymorphism and growth
performance and carcass traits in the chicken population.
Parameter
Genetic Model
Codominant Dominant Recessive Overdominant Log-Additive
BW at 14 days ns ns ns ns ns
BW at 21 days −0.013 0.014 0.606 0.005 0.199
BW at 28 days −0.004 0.002 0.847 0.004 0.035
BW at 35 days −0.004 0.001 0.560 0.008 0.016
BW at 42 days
before slaughter ns ns ns ns ns
trunk weight −0.010 0.013 0.535 0.003 0.215
giblets weight ns ns ns ns ns
abdominal fat
weight ns ns ns ns ns
breast muscle
with skin ns ns ns ns ns
breast muscle
without skin ns ns ns ns ns
thigh muscle
with skin ns ns ns ns ns
thigh muscle
without skin ns ns ns ns ns
slaughter value −0.015 0.646 0.015 0.014 0.306
slaughter
percentage ns ns ns ns ns
BW–body weight; ns–no significant SNP after Bonferroni correction. Statistical significances at significance level
0.05 are highlighted in bold.
Figure 4. Forest plot of body weight (g) of chicken (at 14–42 days of age) of both lines in individual
genotypes. (A) Males; (B) females; (C) total. Statistical characteristics of individual variants: average (n),
median, standard deviation (SD), p-value (compared to average value), minimum (min) and maximum
(max) value. Symbol H is Hubbard F15; C is Cobb E. The line segments represent confidence
interval–CI (95%).
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Figure 5. The weight sum of the trunk, giblets, abdominal fat, breast muscle with and without skin
and thigh muscle with and without skin. IGF1 gene with genotype AA and AC (A), IGFBP2 with
genotype AA and AB (B), TGFβ3 with genotype AA, AB and BB (C). The pink symbol—median,
the grey symbol—mean, square indicates the weight (number of samples). A comparison of individual
genotypes (D). Statistical characteristics of individual variants: number (n), mean and median. The line
segments represent confidence interval–CI (95%); m—males, f—females.
4. Discussion
The study of candidate genes is one of the primary methods to determine whether specific genes
are related to economically important traits in farm animals [69]. We performed genotyping of the
SNP of three genes linked to consumer-priced characteristics in chicken meat.
One of the main hormones required to normal growth process and muscle development is
insulin-like growth factor 1 (IGF-1) [74]. The chicken IGF1 gene consists of four exons and three introns,
spanning more than 50 kb on chromosome 1 [75].
IGF1 encodes the same-name protein (IGF-1), which has a similar molecular structure to insulin [76]
and induces insulin-like metabolic effects in muscle and adipose tissues [65]. This protein plays
an important role in the proliferation, differentiation and metabolism of myogenic cell lines in
chickens [76]. IGF-1 is one of the three ligands (insulin, IGF-1, IGF-2) belonging to the IGF system,
which also includes three cell surface binding receptors (InsR, IGF-1R, IGF-2R), and insulin-like
growth factor binding proteins (IGF binding proteins, IGFBPs) and IGFBP protease [77]. In addition,
the IGF-1 protein is a potent mitogen and an essential stimulus for the differentiation of adipocytes
[78]. The production and secretion of IGF-1 is affected by age, nutritional status, and several
hormones [79]. The predominant source of IGF-1 is the liver and some other tissues, including muscle,
brain and kidney [80].
IGF-1 binds to the type 1 insulin-like growth factor receptor (IGF-1R), which plays a critical role in
signaling cell survival and proliferation [21]. However, IGF-1 can also bind, albeit with lower affinity,
to the insulin receptor [16], regulating some metabolic functions [25].
Insulin-like growth factors (IGFs) provide essential signals for the control of embryonic, as well
as postnatal development in vertebrates [81]. In addition to the growth hormone (GH), IGF-1 is one
of the two main hormones required to support normal growth in chicken. Optimal growth requires
a “set-point” concentration of both IGF-1 and triiodothyronine (T3) in blood circulation. Pituitary
GH plays a role in controlling the circulating levels of both IGF-1 and T3 [74]. IGFs stimulate hepatic
glycogen, increase DNA synthesis and promote tissue growth in chicken [82]. The highest level of
IGF1 mRNA expression was detected in the chicken liver. High levels of IGF1 mRNA (10%–30% of the
value in the liver) were expressed in spleen, lung and brain of chickens. IGF1 mRNA expression was
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also observed in other extrahepatic tissues such as the kidney, heart, intestine, thymus and muscle of
chickens, but these expression levels were less than 4% of that in the liver [83].
The abundant expression of IGF1 gene was detected in the liver of normal chicken, but no IGF1
mRNA expression was found in that organ of dwarf chicken [83]. The expression of hepatic IGF1 mRNA
level and circulating IGF-1 concentration were significantly higher in chicken with a high growth rate,
compared to the line with low growth rate, supporting the hypothesis of its stimulatory effect during
post-hatching growth of chickens as stated by Beccavin et al. [84]. The liver is the main site of IGF-1
production during post-hatch growing stages of chicken as described by Kita et al. [85].
IGF-1 is significantly altered by the genotype, suggesting a pivotal role in the control of growth
rate in broiler chickens [84].
The SNPs within the chicken IGF1 promoter were reported by numerous previous studies [54,86–92]
but according to the author’s best knowledge, no research work on gene constitution of IGF1 SNP in
the Hubbard F15 and Cobb E lines has been reported until now.
Genotype frequency analysis indicated that the AA genotype (73.20%) was of higher frequency
than the AC (26.80%) and CC (0%) genotypes in both chicken lines, which is consistent with another
study [92]. For the other two genes (IGFBP2, TGFβ3), the predominance of heterozygous (AB) genotypes
was detected. Interestingly, in Hubbard F15, a distribution of both allele in TGFβ3 was identical (Table 4).
With regards to the genotype frequencies of IGF1/Hinf I gene polymorphism, from the three known
restriction patterns, only two genotypes were detected: AA and AC, with an almost three times higher
prevalence of AA homozygotes over heterozygotes. The CC homozygous genotype was not found in
either chicken line, which is consistent with the finding of Moe et al. [90], which reported an absence of
the CC genotype in two commercial broiler strains (Chunky and Cobb). The noticeable predominance
of allele A (86.60%) over allele C (13.40%) (Table 4) observed in our study is in conspicuous accordance
with previous studies. As Moe et al. [90] have shown, allele C occurs especially in native chickens,
for example in nine Japanese native chicken breeds (Chabo, Ehime-jidori, Gifu-jidori, Koeyoshi,
Koshamo, Mikawa, Satsuma-dori, Engie and Tokuchijidori), the frequency of this allele to be 1.0.
Our finding of low incidence of C allele in broiler chicken also corresponds with the results of
genotyping performed by Anh et al. [4], who observed the CC genotype of IGF1 gene with very low
frequencies (0.13 to 0.15) in all populations of crossbreds from commercial parent stock broilers with
four Thai synthetic chicken lines (the Kaen Thong, Khai Mook Esarn, Soi Nin, and Soi Pet). The IGF1
SNP gene constitution of these four Thai synthetic chicken lines was studied by Promwatee et al. [92],
who found that the AA genotype had a considerably lower frequency than the AC and CC genotypes
in all chicken lines except Soi Noi, in which the AA and CC genotypes were similar. With the exception
of Soi Nin, there was the predominance of the C allele—the frequency of the A allele was lower than
that of C in all lines except Soi Noi, where both allelic frequencies were the same. This indicates that
allele C is evidently typical for native chicken breeds. A higher frequency of allele A than that of allele
C in commercial broiler stocks compared to native chicken can be explained as a result of selection
effect on growth traits [90].
It can be concluded that the incidence of a higher A allele frequency over C allele in the IGF1 locus
observed in our study could be a result of a long-term selection strategy applied in the populations of
chosen broiler lines that are the subject of this study.
Various studies reported associations between IGF1 polymorphism and growth traits in chickens.
Zhou et al. [54] and Amills et al. [86] reported that polymorphism of the IGF1 gene in the promoter
and 5′-untranslated region (5′-UTR) was directly associated with chicken growth rate. Bian et al. [89]
found that haplotypes based on three IGF1 polymorphisms (c.-366A > C, c.528G > A and c.*1024C >
T–in 5′-flanking, exon 3 and 3′-flanking regions of IGF1) were associated with BW traits.
In our study, AC genotype of IGF1 evinced the highest average BW at 42 days in both chicken
lines. This genotype also corresponded with a higher average AFW, breast muscle weight (with or
without skin), thigh muscle (with or without skin), slaughter value and slaughter percentage in both
lines. On the contrary, the AA genotype of IGF1 was associated with the average lowest BW at 42 days,
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trunk weight, AFW, breast and thigh muscles, slaughter value and slaughter percentage in both lines.
However, no significant difference was identified.
These results are inconsistent with the study of Zhou et al. [54], which observed that broiler line
with fragment sizes of 378, 244 and 191 bp (AA genotype) showed greater improvement of marketable
BW. Additionally, in Thai native chickens, the AA genotype resulted in a higher BW compared to the
AC and CC genotypes [93]. Promwatee et al. [92] found, in two synthetic lines (Khai Mook Esarn,
Soi Pet), the association between the AA genotype and BW at 8 and 12 weeks of age and average
daily gain (ADG) at 0–12 and 0–14 weeks. On the contrary, in the Soi Nin synthetic line, BW at 8 and
12 weeks and ADG at 0–12 weeks were associated with the AC genotype. In the fourth synthetic line
(Kaen Thong), no significant association was found [92]. In Thai native chickens (Chee), the IGF1 gene
was significantly associated with BW at 12 and 16 weeks of age, and ADG during 0–12 and 0–16 weeks
of age [94].
IGFBP-2 binds to insulin-like growth factors [64]. IGFBP-2 is the predominant binding protein
produced during adipogenesis of white preadipocytes [95]. IGFBP-2 is secreted by white adipocytes and
contributes to the prevention of diet-induced obesity [96]. The circulating IGFBP-2 level was significantly
and negatively correlated with fasting plasma glucose, triglycerides, low-density lipoprotein (LDL)
cholesterol, IGF-1, IGF-2 and insulin C-peptide [97].
IGFBP-2 regulates a broad spectrum of physiological processes involved in growth, development,
and differentiation [73]. Both inhibitory and stimulatory effects of IGFBP-2 on cell proliferation have
been reported [98]. IGFBP-2 plays an important role in growth and fat metabolism [64]. IGFBP-2
is the predominant IGF binding protein produced during adipogenesis, and is known to increase
the insulin-stimulated glucose uptake in myotubes [99]. IGFBP-2 stimulates glucose uptake in
a phosphatidylinositol-3-OH kinase (PI3K)-dependent manner. Adipocytes treated with insulin and
IGF-1 for 30 min exhibited a significant (p < 0.001) increase in PI3K phosphorylation when compared
with the control cells. Similarly, IGFBP-2 induced a significant increase in PI3K phosphorylation in
3T3-L1 adipocytes treated for either 30 min (p < 0.01) or 24 h (p < 0.001). Similarly, IGFBP-2 induced
a noticeable increase in AKT phosphorylation in 3T3-L1 adipocytes treated for either 30 min (p < 0.05)
or 24h (p < 0.01) [99]. IGF-1 significantly (p < 0.001) increased, whereas insulin failed to induce (p > 0.05)
AMP-activated protein kinase (AMPK) phosphorylation in 3T3-L1 adipocytes. Similarly, the treatment
of adipocytes with IGFBP-2 for either 30 min or 24 h induced a significant (p < 0.001) increase in AMPK
phosphorylation [99].
Among the seven IGFBPs, IGFBP-2 is the main binding protein secreted by differentiating white
preadipocytes, indicating a potential role in the development of obesity. Overexpression of IGFBP-2
was associated with decreased susceptibility to obesity and improved insulin sensitivity [78]. IGFBP-2
expression was associated with fat mass percentage (p < 0.02). It was demonstrated that IGFBP-2
is expressed by subcutaneous abdominal adipocytes of obese individuals and that the expression
elevated with increasing adiposity and reducing insulin sensitivity [100].
The main functions of IGFBPs are: (1) acting as carrier proteins for circulating IGF-1 and
controller of its flow from the vascular space to tissues; (2) increasing IGF-1 half-life and regulating
its metabolic clearance [101]; (3) modulating the interaction between IGF-1 and its receptor, and thus
indirectly controlling IGF-1 biological activity [102]; (4) modulating IGF-1 in target tissues, inhibiting
or activating its specific actions: cell proliferation, differentiation, survival and migration [62,103–105];
and (5) providing a specific localization pool of IGF-1, because IGFBPs can associate with cell membranes
or the extracellular matrix (ECM) [106]. Moreover, some IGFBPs can possess some biological effects
outside the IGF-1 signaling pathways, such as apoptosis induction and proliferation/inhibition in some
tumors [105].
The IGFBP2 gene has a total length of 32 kb and it is composed by four exons, 2.0 kb (rat) and 1.6 kb
(human) mRNAs are generated, and the mature protein is approximately 31 kDa and 36 kDa in rats
and humans, respectively [107]. The chicken IGFBP2 gene spans to more than 38 kb on chromosome
7 (GGA7), consists of four exons, and presents similar organization compared with rats and humans.
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The chicken IGFBP2 gene is expressed in a majority of tissues, such as liver, muscle, kidney, heart,
ovary, brain, intestine and other tissues [108]. IGFBP2 gene expression was downregulated in the
visceral white adipose tissue of mice, and its circulating levels were reduced in obese mice [96].
Eckstein et al. [109] reported that IGFBP-2 level negatively affected bone size and mineral content in
mice, suggesting it was an important regulator of bone biology in vivo.
As for another gene necessary for growth and development processes, the analysis of IGFBP2/Eco72I
gene polymorphism in the present study showed all three known genotypes (AA, AB, and BB),
with an obvious predominance of the heterozygous genotype (56.70%). However, BB (265 + 102 bp)
homozygotes showed very low frequency (4.12%). The most represented genotype AB (367 + 265 +
102 bp) had a similar frequency to the heterozygotes (53.21%) detected by Li et al. [73], who found
almost identical frequencies of both homozygotes (AA 22.96%, BB 23.83%).
The predominance of A allele over B allele in IGFBP2 locus in our study may be, similarly to IGF1
locus, a long-term selection strategy employed in these chicken populations.
The study of Li et al. [73] indicated that chicken IGFBP2 gene intron 2 C1032T (accession number
AY 326194) polymorphism was associated with growth and body composition traits in an F2 population.
Moreover, the IGFBP2 gene was found to be highly expressed in abdominal fat [73]. QTL for fat
deposition was mapped between the marker brackets LEI0064 and ROS0019 (75 kb to 27 Mb) on GGA7
in the chicken linkage map [57], which covers the chicken IGFBP2 gene (23 to 24 Mb). In Thai native
chickens (Chee), the IGFBP2 gene was significantly associated with body weight at 4 weeks of age,
ADG during 0–4 weeks of age and breast width at 16 weeks of age [94].
An excessive abdominal fat in chickens is undesirable and is therefore sought to be reduced,
in order to improve the quality of the final product. The IGFBP-2 could inhibit the biological actions of
IGF in vivo via endocrine or paracrine mechanisms [22] and indirectly control adipocyte differentiation
by regulating the actions of IGF [67]. The structure and function of the IGFBP2 gene has been
analyzed in detail, however, the association of this gene with growth features in chickens has been
little studied [66].
In our study, heterozygous genotype AB of IGFBP2 resulted—in both chicken lines—in a higher
average BW at 42 days, trunk weight, AFW, breast and thigh muscles, slaughter value and slaughter
percentage compared with AA genotype (Table 6). On average, chickens with the IGFBP2-BB genotype
grew slower and simultaneously deposited less fat in the body. These differences, however, were not
statistically significant. The lowest breast muscle (without skin) was observed in the Hubbard F15 line
chicken with an AA genotype of IGFBP2 (498.75 g).
The findings of higher BW and AFW in heterozygotes in our research are not consistent with
the findings of the study of Li et al. [73], which found that F2 chicken homozygous for the B allele
(IGFBP2-BB) had a higher AFW than birds of the other two genotypes.
The results point to the potential identification of IGFBP2 as a candidate gene for altering the
growth rate and abdominal fat [73]. Reduced growth was associated with increased hepatic IGFBP2
mRNA expression and elevated serum IGFBP-2 levels [22], further suggesting IGFBP-2 as a negative
growth regulator in vivo [73].
TGF-βs are represented in birds and mammals by three isoforms of secreted cytokines TGF-β1,
TGF-β2 and TGF-β3 [70]. The research of Li et al. [69] supported the broad effects of TGFβ genes on
the growth and development of chickens. Recently, eight from 17 polymorphic sites of the TGFβ3
gene [53 (T → C), 1653 (C → T), 1755 (A → G), 3343 (C → T), 3540 (C → T), 4786 (C → T), 7263
(C→ T) and 7471 (G→ A)] have been significantly related to reproduction traits, indicating these
polymorphic sites as potential assistant selection markers for improvement of reproductive capacity of
Liboyaoshan chicken [110].
The TGFβ3 gene could be a marker for genetically improving duration fertility in hens. In the
recent study performed by Gu et al. [111], four SNPs were identified in intron 1 of TGFβ3, and were
significantly associated with the duration of fertility in hens (p < 0.05). In addition, they identified
multi-copy and copy number variants (CNVs) in chicken TGFβ3, and later determined significant
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associations between TGFβ3 CNVs and duration fertility in hens. Specifically, the TGFβ3 copy number
exhibited a significant positive correlation with its expression (p < 0.05).
A significant association between the TGFβ3-BsrI polymorphism and mortality between 14 and
42 days in broiler chickens was reported by Ye et al. [112].
In addition, significant effects of TGFβ3-BsrI polymorphism on the cecum content Salmonella enteritidis
bacterial load were found [113], which could have been of great importance, especially in commercial
broiler chicken farms. A moderate association (p < 0.17) was found between the TGFβ3-BsrI sire allele and
antibody response to the S. enteritidis vaccine [113]. Polymorphism in the restriction site of TGFβ3-BsrI was
associated with S. enteritidis burden. The heterozygote A/C had the highest S. enteritidis burden in the cecum,
spleen and liver compared with the other two genotypes (p < 0.01). The C/C genotype of TGFβ3 showed the
lowest bacterial burden for Village Chickens, whereas in Red Junglefowl, the A/A genotype exhibited the
lowest S. enteritidis colonization [114]. Salmonella enterica serovar Enteritidis infection is a common concern
in poultry production for its negative effects on growth, as well as food safety for humans [114].
In the study of Li et al. [69], the TGFβ3 polymorphism in broilers crossed with Leghorn was
associated with traits of growth and body composition, such as BW, ADG, breast muscle weight,
abdominal fat and spleen weight. In our study, for the TGFβ3 gene, AB genotype was the most common
in both chicken lines. The allele A was identified as a dominant allele in Cobb E (64.89%), whereas in
Hubbard F15, the frequency of both alleles was identical. This finding is different from another study
analyzing TGFβ3 genotypes in breeder hens [115], where the allele B was a dominant allele at TGFβ3
locus, due to it having the highest frequency (0.81).
For the TGFβ3 gene, different tendencies were observed in the association of the A and B alleles
with the traits observed within both chicken lines. In Cobb E, the AB genotype of TGFβ3 resulted in the
highest average BW at 42 days (3104.29 g). The highest AFW had Cobb E chicken with AA genotype of
TGFβ3 (54.95 g). On the contrary, in Hubbard F15, the highest average BW at 42 days and AFW were
observed in chickens with the BB genotype (2618.00 g, 37.33 g, respectively).
The highest average breast muscle (without skin) was found in the AB genotype of TGFβ3 in both
lines (in Cobb E chicken: 653.62 g and in Hubbard F15: 515.55 g). The highest average thigh muscle
(with skin) was also found in the AB genotype of TGFβ3 in both lines, with the highest average value
in Cobb E (Cobb E: 538.72 g, Hubbard F15: 476.75 g).
On the contrary, the lowest average value of BW at 42 days was observed in the AA genotype of
TGFβ3 in both lines (in the Hubbard F15 line chicken with the AA genotype: 2541.33 g and in Cobb E
in individuals with the AA genotype: 2778.50 g). The lowest AFW was found in the chicken with the
AA genotype in the Hubbard F15 line (31.53 g), and in Cobb E in birds with the heterozygous genotype
AB (48.90 g). The lowest breast muscle (without skin) was in the Hubbard F15 line chicken with the AA
genotype of TGFβ3 (494.33 g) and in Cobb E in the birds with the BB genotype (551.00 g). The lowest
thigh muscle (with skin) was observed in the Hubbard F15 line chicken with the AA genotype (469.00 g),
and in the Cobb E line chicken with the BB genotype of TGFβ3 (458.67 g).
Association analysis showed that BslI genotypes of TGFβ3 are related to some performance
traits (Table 8). The statistical analysis revealed a significant association of TGFβ3 with BW at 21,
28 and 35 days and trunk weight in the codominant (negative value), dominant and overdominant
(positive values) genetic model, and with slaughter value in codominant (negative value), recessive and
overdominant (positive values) genetic model.
The average slopes of the growth curve (14–42 days of age) constructed according to the line,
genotype and sex (Figure 4) was confirmed to be a result of linear growth, as well as lineage and
sex differences in body weight. Constructing the graphs of total integrals for the weight sum of
the trunk, giblets, abdominal fat, breast and thigh muscles at 42 days of age (at the slaughter of
chickens) in both chicken lines (with a separate evaluation of both sexes) and all genotypes observed
(Figure 5) showed interesting tendencies. However, no statistically significant dependence was
observed, despite apparent differences.
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5. Conclusions
The presented study demonstrated that the point mutation can affect chicken growth,
and confirmed some significant associations between SNP and growth traits. Based on these findings,
it can be concluded that the TGFβ3 gene could be applied as a candidate gene marker for chicken
growth traits in the Hubbard F15 and Cobb E broiler line population selection program. However,
further association analysis will be required to clarify the effects of this marker on growth and
production traits in the broiler chicken population.
Author Contributions: All authors participated in the manuscript. B.H. performed genetic analyses and wrote
manuscript, K.V. optimized laboratory methodology, performed genetic analyses and participated in writing
manuscript, R.K. evaluated experimental data and critically revised the manuscript, R.B. evaluated genetic
analyses, J.K. collected samples and revised manuscript, V.C. expertly revised the manuscript, F.K. and C.F. revised
manuscript, V.M. and H.H. were responsible for running and conducting the experiment. All authors have read
and agreed to the published version of the manuscript.
Funding: This work was supported by the project of the Ministry of Education, Youth and Sports of the Czech
Republic No. MSM 6007665806.
Acknowledgments: The authors would like to thank a state-owned enterprise International Testing of Poultry
Ustrasice (Czech Republic) for performing production trait analysis, Vaclav Rehout for support for research,
and Ing. Jana Karlickova and Irena Vankova Nestavalova for their technical assistance. The authors would
also like to thank Josef Ruzicka for the development of the laboratory information system Qinslab (Prevention
Medicals, Studenka, Czech Republic). CF would like to express his gratitude to RGU for its support.
Conflicts of Interest: The authors declare no conflict of interest.
Abbreviations
ADG average daily gain
AFW abdominal fat weight
AKT serine/threonine kinase
AMP adenosine monophosphate
AMPK AMP-activated protein kinase
BACs bacterial artificial chromosomes
BAD BCL-2 antagonist of cell death
BCL-2 antiapoptotic B-cell lymphoma/leukemia-2
bp base pairs
BW body weight
CI confidence interval
CNVs copy number variants
cM centimorgan
DNA deoxyribonucleic acid
ECM extracellular matrix
EDTA ethylenediaminetetraacetic acid
ERK extracellular signal-regulated kinase
FOXO Forkhead box, class O; subfamily of Forkhead transcription factors
Gb giga base pairs
GGA1, GGA7 Gallus gallus autosome 1, Gallus gallus autosome 7
GH growth hormone
GSK-3β glycogen synthase kinase-3β
HWE Hardy-Weinberg equilibrium
IGF insulin-like growth factor
IGF-1 insulin-like growth factor 1
IGF1 insulin-like growth factor 1 gene
IGF-1R the type 1 insulin-like growth factor receptor
IGF-2R the type 2 insulin-like growth factor receptor
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IGFBP insulin-like growth factor binding protein
IGFBP-2, IGFBP-3 insulin-like growth factor binding protein 2, 3
IGFBP2 insulin-like growth factor binding protein 2 gene
InsR insulin receptor
IRS insulin receptor substrate
IU international units
kb kilobase pairs
LDL low-density lipoprotein
MAP mitogen-activated protein
MAPK mitogen-activated protein kinase
Mb megabase pairs
MEK mitogen-activated protein kinase kinase 7 (MAP2K7)
MMAS molecular marker-assisted selection
mRNA messenger RNA
mTOR mammalian target of rapamycin
mTOR-C1, mTOR-C2 complexes of mTOR
p27 a protein of 27 kDa that regulates the cell cycle
PI3K phosphatidylinositol-3-OH kinase
PCR polymerase chain reaction
PDK1 3-phosphoinositide-dependent protein kinase-1
QTL quantitative trait locus
RAF proto-oncogene serine/threonine-protein kinase
RAS a protein playing a key role in signal transduction of cell growth and differentiation
RFLP restriction fragment length polymorphism
S6K-1/2 ribosomal protein S6 kinase 1/2
SD standard deviation
SHC the SRC homology and collagen protein
SMADs proteins that are the main signal transducers for receptors of TGFß
SNP single nucleotide polymorphism
SRC proto-oncogene tyrosine-protein kinase
T3 triiodothyronine
TBE buffer Tris-borate-EDTA buffer
TGFß transforming growth factor β
TGFß3 transforming growth factor β3 gene
TSC-1/2 tuberous sclerosis protein 12
4E-BP1 eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1
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